Metabolism of amiodarone (Part III): identification of rabbit cytochrome P450 isoforms involved in the hydroxylation of mono-N-desethylamiodarone

References

• BALDWIN, S., BLOOMER, J. C., SMITH, G. J., AYRTON, A. D., CLARKE, S. E. and CHENERY, R. J., 1995, Ketoconazole and sulphaphenazole as the respective selective inhibitors of P450 3A and 2C9. Xenobiotica, 25, 261–270.
   PubMed Web of Science ®Google Scholar
• BENSADOUN, A. and WEINSTEIN, D., 1976, Assay of protein in the presence of interfering materials. Analytical Biochemistry, 70, 241–250.
   PubMed Web of Science ®Google Scholar
• BERTAULT -PERES, I., BONIS, C., PADRE, G., JUST, S., Co, J. P. and MAUREL, P., 1987, Metabolism of cyclosporin A. II. Implication of macrolide antibiotic inducible cytochrome P-450 3c from rabbit liver microsomes. Drug Metabolism and Disposition, 15, 391–398.
   Google Scholar
• DAUJAT, M., CLAIR, P., ASTIER, C., FABRE, I., PINEAU, T., YERLE, M., GELLIN, J. and MAUREL, P., 1991, Induction, regulation and messenger half-life of cytochromes P450 IAL IA2 and IIIA6 in primary cultures of rabbit hepatocytes. European Journal Pharmacology, 200, 501–510.
   Google Scholar
• DAUJAT, M., PICHARD, L., DALET, C., LARROQUE, C., BONIS, C., POMPON, D., Li, D., GUZELIAN, P. S. and MAUREL, P., 1987, Expression of five forms of microsomal cytochrome P450 in primary cultures of rabbit hepatocytes treated with various classes of inducers. Biochemical Pharmacology, 36, 3597–3606.
   PubMedGoogle Scholar
• DAYER, P., KRONBACH, T., EICHELBAUM, M., COVO, J. and MEYER, U. A., 1987, Enzymatic basis of the debrisoquine/sparteine-type genetic polymorphism of drug oxidation. Characterization of bufuralol -hydroxylation in liver microsomes of in vivo phenotyped carriers of the genetoc deficiency. Biochemical Pharmacology, 36, 4145–4152.
   PubMed Web of Science ®Google Scholar
• FABRE, G., CREVATPISANO, P., DRAGNA, S., COVO, J., BAR, Y. and CANO, J. P., 1988, Involvement of the macrolide antibiotic inducible cytochrome P-450 LM3c in the metabolism of midazolam by microsomal fractions prepared from rabbit liver. Biochemical Pharmacology, 37, 1947–1953.
   PubMedGoogle Scholar
• FABRE, G., JULIAN, B., SANF-AUBERT, B., JoyEux, H. and BERGER, Y., 1993, Evidence for CYP3A-mediated N-deethylation of amiodarone in human liver microsomal fractions. Drug Metabolism and Disposition, 21, 978–985.
   Google Scholar
• GUENGERICH, F. P., MUELLER-ENOCH, D. and BLAIR, I. A., 1986, Oxidation of quinidine by human liver cytochrome P-450. Molecular Pharmacology, 30, 287–295.
   Google Scholar
• HA, H. R., BIGLER, L., BINDER, M., KOZLIK, P., HESSE, M., ALTORFER, H. R. and FOLLATH, F., 2001, Metabolism of amiodarone (Part I): identification of a new hydroxylated metabolite of amiodarone. Drug Metabolism and Disposition, 29, 152–158.
   PubMed Web of Science ®Google Scholar
• HA, H. R., CANDINAS, R., STIEGER, B., MEYER, U. A. and FOLLATH, F., 1996, Interaction between amiodarone and lidocaine. Journal of Cardiovascular Pharmacology, 26, 533–539.
   Google Scholar
• HA, H. R., Kozt.m, P., STIEGER, B., BIGLER, L. and FOLLATH, F., 2000, Metabolism of amiodarone (Part II): high-performance liquid chromatographic assay for mono-N-desethylamiodarone hydroxylation in liver microsomes. Journal of Chromatography B, Biomedical Application (in press, April 2001).
   Google Scholar
• HA, H. R., RENrscR, K. M., KNEER, J. and VONDERSCHMITT, D. J., 1993, Determination of midazolam and its a-hydroxy metabolite in human plasma and urine by high-performance liquid chromatography. Therapeutic Drug Monitoring, 15, 338–343.
   Google Scholar
• HA, H. R., Wyss, P., STIEGER, B., MEYER, U. A. and FOLLATH, F., 1992, Amiodarone metabolism in human liver microsomes. FASEB Journal, 6, A1845 (abstract).
   Google Scholar
• KANNAN, R., MILLER, S. and SINGH, B. N., 1985, Tissue uptake and metabolism of amiodarone after chronic administration in rabbits. Drug Metabolism and Disposition, 13, 646–650.
   PubMed Web of Science ®Google Scholar
• KOOP, D. R., PERSSON, A. V. and COON, M. J., 1981, Properties of electrophoretically homogeneous constitutive forms of liver microsomal cytochrome P-450. Journal of Biological Chemistry, 256, 10704–10711.
   PubMedGoogle Scholar
• MEIER, P. J., SIYCHER, M. A. and MEYER, U. A., 1981, Isolation and characterization of rough endoplasmic reticulum associated with mitochondria from normal rat liver. Biochemica et Biophysica Acta, 46, 283–297.
   Google Scholar
• PICHARD, L., GILLET, G., FABRE, I., DALET-BELUCHE, I., BONIS, C., THENOT, J. P. and MAUREL, P., 1990, Identification of the rabbit and human cytochromes P-45011IA4 as the major enzymes involved in the N-demethylation of diltiazem. Drug Metabolism and Disposition, 18, 711–719.
   Google Scholar
• PLOMP, T. A., 1991, Analytical profiles of amiodarone. In K. Florey (ed.), Analytical Profiles of Drug Substances, vol. 20 (San Diego: Academic Press), pp. 2–120.
   Google Scholar
• STOREY, G. C. A., ADAMS, P. C., CAMPBELL, R. W. F. and HOLT, D. W., 1969, High-performance liquid chromatographic measurement of amiodarone and desethylamiodarone in small tissue samples after enzymatic digestion. Journal of Clinical and Pathology, 177, 340–352.
   Google Scholar
• VON MOLTKE, L. L., GREEBLATT, D. J., SCHMIDER, J., DUAN, S. X., WRIGHT, C. E., HARMATZ, J. S. and SHADER, R. I., 1996, Midazolam hydroxylation by human microsomes in vitro: inhibition by fluoxetine, norfluoxetine and by azole antifungal agents. Journal of Clinical Pharmacology, 36, 783–791.
   Google Scholar
• WAXMAN, D. J., ATTISANO, C., GUENGUERICH, F. P. and LAFENSON, D. P., 1988, Human liver microsomal steroid metabolism: identification of the major microsomal steroid hormone 6-hydroxylase cytochrome P450 enzyme. Archives of Biochemistry and Biophysics, 263, 424–436.
   PubMed Web of Science ®Google Scholar
• WRIGHTON, S. A., MAUREL, P., SCHUETZ, E. G., WATKINS, P. B., YOUNG, B. and GUZELIAN, P. S., 1985, Identification of the cytochrome P-450 induced by macrolide antibiotic in rat liver as the glucocorticoid responsive cytochrome P-450p. Biochemistry, 24, 2171–2178.
   PubMed Web of Science ®Google Scholar
• ZAREMBSKI, D. G., FISCHER, S. A., SANTUCCI, P. A., PORTER, M. T., COSTANZO, M. R. and TRODMAN, R. G., 1999, Impact of rifampicin on serum amiodarone concentrations in a patient with congenital heart disease. Pharmacotherapy, 19, 249–251.
   Google Scholar